Tag: Kidney transplant

According to numerous transplant and nephrology guidelines, non-steroidal anti-inflammatory drugs (NSAIDs) like Aleve should be avoided after a kidney transplant. The potential for damage to the transplanted organ is a serious concern, making it critical for patients to understand why these common pain relievers pose a significant risk to their long-term health. This guide will detail the risks associated with taking Aleve after a kidney transplant and provide safer, expert-recommended alternatives.

Tacrolimus is a powerful immunosuppressant vital for preventing organ rejection after transplants [1.8.3]. Discontinuing this medication, a process known as withdrawal, must be medically supervised due to the significant risks and symptoms that can arise. So, what are the withdrawal symptoms of tacrolimus?

While tacrolimus has revolutionized organ transplant outcomes, it is not always effective, with some patients experiencing acute rejection despite therapy. In cases of tacrolimus rejection, clinicians must turn to a range of alternative or supplementary medications to stabilize the allograft and prevent irreversible damage. This comprehensive guide explores the pharmacology and management strategies for dealing with rejection when a patient is already on tacrolimus.

Originally developed in the early 1980s, Sandimmune (cyclosporine) is a potent immunosuppressant medication used to manage life-threatening immune responses in patients receiving organ transplants. It also plays a vital role in treating severe autoimmune conditions that have not responded adequately to other treatments.